Canaan Partners X LLC Next Cure, Inc. Transaction History

Canaan Partners X LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$5.7 - $9.1 $1.83 Million - $2.93 Million	-321,647 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$6.74 - $8.02 $3.48 Million - $4.14 Million	-516,795 Reduced 61.64%	321,647 $2.17 Million
Q4 2020 Feb 02, 2021	SELL	$9.47 - $12.43 $8.27 Million - $10.9 Million	-873,071 Reduced 51.01%	838,442 $9.14 Million
Q3 2020 Oct 26, 2020	SELL	$8.15 - $21.17 $2.58 Million - $6.71 Million	-316,929 Reduced 15.62%	1,711,513 $15.1 Million
Q1 2020 May 11, 2020	SELL	$32.32 - $58.37 $7.3 Million - $13.2 Million	-226,000 Reduced 10.02%	2,028,442 $75.2 Million
Q4 2019 Jan 27, 2020	BUY	$25.0 - $92.22 $56.4 Million - $208 Million	2,254,442 New	2,254,442 $127 Million

16M

1.4K

Ticker NXTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,748,800
Market Cap $39.4M
Description
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The comp...

Get notified when there are updates to the investment portfolio of Canaan Partners X LLC, based on Form 13F filings with the SEC.

Stay updated on Canaan Partners X LLC with notifications on news.